Showing results (181-190 of 289) with videos related to
Sort By:
Pageof 29
Arthritis and Rheumatism|March 1, 1987
Failure of Klebsiella pneumoniae antibodies to cross-react with peripheral blood mononuclear cells from patients with ankylosing spondylitisF H Cameron, P J Russell, J F Easter, et al.Radiation Oncology Investigations|May 20, 1999
Comparison between the clonogenic, MTT, and SRB assays for determining radiosensitivity in a panel of human bladder cancer cell lines and a ureteral cell lineD Banasiak, A R Barnetson, R A Odell, et al.The Prostate|April 16, 1998
Relative activity and specificity of promoters from prostate-expressed genesD E Brookes, D Zandvliet, F Watt, et al.Prostate Cancer and Prostatic Diseases|March 29, 2003
Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell linesM M Daja, X Niu, Z Zhao, et al.European Journal of Cancer & Clinical Oncology|May 1, 1987
Patient treatment preference in advanced breast cancer: a randomized cross-over study of doxorubicin and mitozantroneR Stuart-Harris, R J Simes, A S Coates, et al.British Medical Journal (Clinical Research Ed.)|October 25, 1986
Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment for cancerR J Simes, M H Tattersall, A S Coates, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Phase II trial of carboplatin in the management of malignant mesotheliomaD Raghavan, P Gianoutsos, J Bishop, et al.Seminars in Oncology|October 1, 1995
Phase I study of paclitaxel and carboplatin: implications for trials in head and neck cancerP Creaven, D Raghavan, L Pendyala, et al.The Annals of Thoracic Surgery|April 1, 1982
Mediastinal nonseminomatous germ cell tumors: the role of combined modality therapyN J Vogelzang, D Raghavan, R W Anderson, et al.The Medical Journal of Australia|May 18, 1992
Combination chemotherapy with cisplatin, vindesine and mitomycin-C for advanced, inoperable non-small-cell lung cancerM Stockler, D Raghavan, B C McCaughan, et al.Pageof 29